Suppr超能文献

人中性粒细胞趋化因子/激活蛋白-1的白细胞特异性及结合

Leukocyte specificity and binding of human neutrophil attractant/activation protein-1.

作者信息

Leonard E J, Skeel A, Yoshimura T, Noer K, Kutvirt S, Van Epps D

机构信息

Immunopathology Section, National Cancer Institute, Frederick, MD 21701.

出版信息

J Immunol. 1990 Feb 15;144(4):1323-30.

PMID:2406341
Abstract

Neutrophil attractant/activation protein-1 (NAP-1) was previously shown to attract human neutrophils, but not monocytes. The purpose of this study was to determine if NAP-1 interacted with other types of blood leukocytes. In addition to its chemotactic activity for neutrophils, NAP-1 induced chemotactic responses by T lymphocytes and basophils. Chemotactic potency (10(-8) M for an optimal response) was the same for all three cell types. However, NAP-1 caused a chemotactic response in excess of random migration of 7% or 16% of basophils (depending on the medium used) and only 9% of T lymphocytes, in contrast to 30% of neutrophils. This agonist was not chemotactic for partially purified normal human eosinophils. The symmetrical histogram obtained by flow cytometry of neutrophils equilibrated at 0 degree C with fluoresceinated NAP-1 indicates that all neutrophils bound the ligand. A dose-response curve plateau, and inhibition of binding of NAP-1-FITC by unlabeled ligand are evidence for saturable binding to receptors, estimated to be 7000 per cell. Our results suggest that, for induction of an acute inflammatory response, the quantitatively significant action of NAP-1 is on neutrophils.

摘要

中性粒细胞趋化因子/激活蛋白-1(NAP-1)先前已被证明可吸引人类中性粒细胞,但不能吸引单核细胞。本研究的目的是确定NAP-1是否与其他类型的血液白细胞相互作用。除了对中性粒细胞具有趋化活性外,NAP-1还可诱导T淋巴细胞和嗜碱性粒细胞产生趋化反应。三种细胞类型的趋化效力(最佳反应浓度为10^(-8) M)相同。然而,NAP-1引起的趋化反应超过了嗜碱性粒细胞随机迁移的7%或16%(取决于所用培养基),T淋巴细胞仅为9%,而中性粒细胞为30%。该激动剂对部分纯化的正常人嗜酸性粒细胞无趋化作用。用荧光素标记的NAP-1在0℃下平衡中性粒细胞后通过流式细胞术获得的对称直方图表明,所有中性粒细胞均结合了该配体。剂量反应曲线的平台期以及未标记配体对NAP-1-FITC结合的抑制作用证明了与受体的饱和结合,估计每个细胞有7000个受体。我们的结果表明,对于诱导急性炎症反应,NAP-1在数量上的显著作用是针对中性粒细胞的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验